Author： Kawada N. Uoya M. Seki S. Kuroki T. Kobayashi K.
Publisher： Elsevier
ISSN： 0006-291X
Source： Biochemical and Biophysical Research Communications, Vol.233, Iss.2, 1997-04, pp. : 464-469
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Previously we reported that dibutyryl cAMP and phosphodiesterase inhibitor methylxanthines block rat stellate cell proliferation. To analyze the underlying mechanism, modulation by these agents of platelet-derived growth factor (PDGF)/BB-stimulating signal pathway was studied. Without reducing STAT1 protein level, these agents were found to attenuate STAT1 activation in stellate cells stimulated with PDGF/BB as revealed by an electrophoretic mobility shift assay. Inhibitory effect started 12 h after exposure of the cells to these agents at concentrations of more than 100 muM. These agents had no effects on DNA binding activity of STAT1 that had already been activated. Treatment with these agents failed to affect the function of PDGF receptors except for partial attenuation of phospholipase C activation under PDGF/BB stimulation. The present results indicate that inhibition of STAT1 activation may be one of factors involved in the cAMP-dependent stellate cell growth arrest.
Related content
Access to resources
Recommend
Transcriptional regulation by cAMP in the heart
By Müller F.U. Neumann J. Schmitz W.
Molecular and Cellular Biochemistry, Vol. 212, Iss. 1-2, 2000-09 ,pp. :
By Kim N.N. Huang Y-h. Moreland R.B. Kwak S.S. Goldstein I. Traish A.
Molecular Cell Biology Research Communications, Vol. 4, Iss. 1, 2000-07 ,pp. :
By Plopper G.E. Huff J.L. Rust W.L. Schwartz M.A. Quaranta V.
Molecular Cell Biology Research Communications, Vol. 4, Iss. 2, 2000-08 ,pp. :